Reynold A. Panettieri Jr., MD, explores the impact of COPD and asthma on patients' quality of life, highlighting exercise limitations and sleep disturbances. Jonathan Silverberg, MD, PhD, MPH, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients were aged 40 to 69 years when they were ...

High airway TSLP asthma is linked to severe disease, type 2 inflammation, and airway remodelling. Learn more about how TSLP may guide targeted treatment.

Panelists discuss how identifying type 2 inflammation in patients influences treatment decisions by steering clinicians toward targeted therapies, such as biologics or other immunomodulators, that ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Asthma and cardiovascular diseases (CVDs) are intricately linked, because of their widespread prevalence ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In those with and those without emphysema, patients ...

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -- dupilumab -- that showed rapid and sustained improvements in patients in a pivotal Phase 3 ...

Obesity, inflammation, and type 2 diabetes are interconnected in a cyclical way. Obesity causes chronic inflammation, which helps drive the development and progression of type 2 diabetes. Diabetes, in ...

24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD ...

Dupilumab significantly reduced exacerbations and improved lung function in adults with uncontrolled chronic obstructive pulmonary disease (COPD) and type 2 inflammation, based on data from more than ...